Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Debbie C. Strachan"'
Autor:
Debbie C. Strachan, Christine J. Gu, Ryosuke Kita, Erica K. Anderson, Michelle A. Richardson, George Yam, Graham Pimm, Jordan Roselli, Alyssa Schweickert, Maci Terrell, Raushan Rashid, Alan K. Gonzalez, Hailey H. Oviedo, Michelle C. Alozie, Tamilini Ilangovan, Andrea N. Marcogliese, Hiroomi Tada, Marianne T. Santaguida, Alexandra M. Stevens
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6240
Acute myeloid leukemia (AML) is a heterogeneous disease that accounts for ~20% of all childhood leukemias, and more than 40% of children with AML relapse within three years of diagnosis. Although recent efforts have focused on developing a precise me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f07aba0a4a88ba41940b90b378f763
https://doi.org/10.3390/cancers14246240
https://doi.org/10.3390/cancers14246240
Autor:
Hailey H Oviedo, Christine Gu, Erica K. Anderson, Ryosuke Kita, Debbie C. Strachan, Michelle C Alozie, Alan K Gonzalez, Noah J Keogh, Alexandra M. Stevens, Raushan Rashid, Michelle A Richardson, Andrea N. Marcogliese, Maci Terrell, Marianne Santaguida
Publikováno v:
Blood. 138:2361-2361
Background Pediatric acute myeloid leukemia (AML) is a rare disease with roughly 600 cases diagnosed in the United States each year with minimal improvement in clinical outcomes over the last few decades. We previously demonstrated that an ex vivo dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d3876be895ce4297af19d6b111a00b5
https://doi.org/10.1182/blood-2021-145275
https://doi.org/10.1182/blood-2021-145275
Autor:
Joseph Wagner, Wade C. Anderson, Laura Henry, Debbie C. Strachan, Kamran A Ali, Susanna Wen, Marianne Santaguida, Ryosuke Kita, Erica K. Anderson, Allen Ling, Arisa Paul, Joseph R. Pressley, Colin W. Dailey, Kristen Dempsey, Santhosh Balasubramanian, Steven Schaffert, Kathryn Vanderlaag, Markus D. Lacher
Publikováno v:
Journal of Clinical Oncology. 39:e19013-e19013
e19013 Background: Understanding the heterogeneity of AML is necessary for developing targeted drugs and diagnostics. A key measure of heterogeneity is the variance in response to treatments. Previously, we developed an ex vivo flow cytometry drug se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::359c2636b23974120a10d8ad8de72706
https://doi.org/10.1200/jco.2021.39.15_suppl.e19013
https://doi.org/10.1200/jco.2021.39.15_suppl.e19013
Autor:
Michelle A Richardson, Maci Terrell, Debbie C. Strachan, Andrea N. Marcogliese, Erica K. Anderson, Ryosuke Kita, Raushan Rashid, Marianne Santaguida, Alexandra M. Stevens
Publikováno v:
Journal of Clinical Oncology. 39:10032-10032
10032 Background: Pediatric acute myeloid leukemia (AML) is a rare disease with roughly 500 cases diagnosed in the United States each year and has had minimal improvement in clinical outcomes over recent decades. Novel treatment development to improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6db17b556c506e2e608237ba41386008
https://doi.org/10.1200/jco.2021.39.15_suppl.10032
https://doi.org/10.1200/jco.2021.39.15_suppl.10032
Autor:
Debbie C Strachan, Dylan Daniel, Brian Ruffell, Lisa M. Coussens, Yoko Oei, Nancy Pryer, Mina J. Bissell
Publikováno v:
Oncoimmunology
Increased numbers of tumor-infiltrating macrophages correlate with poor disease outcome in patients affected by several types of cancer, including breast and prostate carcinomas. The colony stimulating factor 1 receptor (CSF1R) signaling pathway driv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd57d17f03b388989310e94ecf79162
http://europepmc.org/articles/PMC3902121
http://europepmc.org/articles/PMC3902121